United States - English - NLM (National Library of Medicine)

hospira, inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 160 mg in 100 ml

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 300 mg

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline anhydrous 100 mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

s.c zentiva s.a - colchicine - tablets - 1mg

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - theophylline anhydrous (unii: 0i55128jyk) (theophylline anhydrous - unii:0i55128jyk) - theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. theophylline extended-release tablets are contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product.

United States - English - NLM (National Library of Medicine)

teva select brands - pimozide (unii: 1hiz4dl86f) (pimozide - unii:1hiz4dl86f) - orap (pimozide) is indicated for the suppression of motor and phonic tics in patients with tourette’s disorder who have failed to respond satisfactorily to standard treatment. orap is not intended as a treatment of first choice nor is it intended for the treatment of tics that are merely annoying or cosmetically troublesome. orap should be reserved for use in tourette’s disorder patients whose development and/or daily life function is severely compromised by the presence of motor and phonic tics. evidence supporting approval of pimozide for use in tourette’s disorder was obtained in two controlled clinical investigations which enrolled patients between the ages of 8 and 53 years. most subjects in the two trials were 12 or older. - orap (pimozide) is contraindicated in the treatment of simple tics or tics other than those associated with tourette’s disorder. - orap should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (e.g., pemoline, methylphenidate and amphetamines) un

United States - English - NLM (National Library of Medicine)

hospira, inc. - aminophylline dihydrate (unii: c229n9dx94) (theophylline anhydrous - unii:0i55128jyk) - intravenous theophylline is indicated as an adjunct to inhaled beta-2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases, e.g., emphysema and chronic bronchitis. aminophylline is contraindicated in patients with a history of hypersensitivity to theophylline or other components in the product including ethylenediamine.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

s.c zentiva s.a - colchicine - tablets - 1mg